Printer Friendly

ROCHESTER MEDICAL REPORTS FOURTH QUARTER PROFIT

 STEWARTVILLE, Minn., Nov. 9 /PRNewswire/ -- Rochester Medical Corporation (NASDAQ: ROCM) today announced sales and net profit for the fourth quarter ended Sept. 30, 1993.
 Net sales for the fourth quarter and 12 months ended Sept. 30, 1993, were $612,530 and $1,392,677 compared to $37,653 and $374,981 for the year earlier periods, respectively.
 The company reported net income of $19,261 or $.01 per share for the fourth quarter with a net loss of $634,985 (or $.24 per share) for the 12 months ended Sept. 30, 1993, compared to net loss of $385,468 or ($.14 per share) and $810,611 (or $.30 per share), for the year earlier periods, respectively.
 "We are pleased to report our first profitable quarter," said Anthony J. Conway, ROCM's president. "We expect to continue sales and earnings growth as we expand our marketing efforts during the coming year and as our products become more familiar to the marketplace. We are also pleased with progress in new product development and expect to have further announcements in the coming months."
 ROCM develops, manufactures and markets latex free disposable medical catheters for urological applications.
 ROCHESTER MEDICAL CORPORATION
 Fourth Quarter Ended 12 Months Ended
 9/30/93 9/30/92 9/30/93 9/30/92
 Net sales $612,530 $37,653 $1,392,677 $374,981
 Net income (loss) 19,261 (385,468) (634,985) (810,611)
 Net income (loss)
 per share $.01 $(.14) $(.24) $(.30)
 Average common shares
 outstanding 2,660,000 2,660,000 2,660,000 2,660,000
 -0- 11/9/93
 /CONTACT: Anthony J. Conway, president of Rochester Medical, 507-533-4203/
 (ROCM)


CO: Rochester Medical Corporation ST: Minnesota IN: MTC SU: ERN

DS-DB -- MN021 -- 2496 11/09/93 18:05 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 9, 1993
Words:293
Previous Article:MOMENTUM CORP. TO REPURCHASE SHARES
Next Article:MEDIMMUNE PRODUCT SALES CONTINUE TO GROW IN THIRD QUARTER
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters